United Therapeutics Corporation (UTHR)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 262.40 |
| Open | 261.88 |
| Bid | 260.05 x 200 |
| Ask | 260.58 x 100 |
| Day's Range | 256.08 - 264.79 |
| 52 Week Range | 204.44 - 264.79 |
| Volume | |
| Avg. Volume | 520,561 |
| Market Cap | 11.558B |
| Beta (5Y Monthly) | 0.55 |
| PE Ratio (TTM) | 12.33 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GuruFocus.com
Insider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR)
On May 3, 2024, Judy Olian, Director at United Therapeutics Corp (NASDAQ:UTHR), executed a sale of 10,000 shares of the company.
- GuruFocus.com
Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR)
On May 3, 2024, Director Christopher Causey sold 2,240 shares of United Therapeutics Corp (NASDAQ:UTHR) as reported in a recent SEC Filing.
- Zacks
United Therapeutics (UTHR) is an Incredible Growth Stock: 3 Reasons Why
United Therapeutics (UTHR) possesses solid growth attributes, which could help it handily outperform the market.
© 2024 Yahoo. All rights reserved.